Clinical Trials
8
Active:0
Completed:4
Trial Phases
3 Phases
Phase 2:1
Phase 3:1
Not Applicable:6
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Not Applicable
6 (75.0%)Phase 2
1 (12.5%)Phase 3
1 (12.5%)A Trial to Assess the Efficacy and Safety of OTR4132-MD in Patients with Acute Ischemic Stroke
Phase 2
Not yet recruiting
- Conditions
- Endovascular ThrombectomyIschemic Cerebrovascular Accident
- First Posted Date
- 2024-11-22
- Last Posted Date
- 2024-11-26
- Target Recruit Count
- 60
- Registration Number
- NCT06700824
- Locations
- 🇫🇷
Centre Hospitalier Universi-taire de Bordeaux-Hôpital Pellegrin, Bordeaux, France
🇫🇷Centre hospitalier universi-taire de Brest (Cavale Blanche), Brest, France
🇫🇷CHU Henri-Mondor, Créteil, France
CACIPLIQ20 in Wound Healing in Subjects With Epidermolysis Bullosa
Not Applicable
Recruiting
- Conditions
- Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa, Junctional
- Interventions
- Device: CACIPLIQ20Drug: Placebo
- First Posted Date
- 2023-08-23
- Last Posted Date
- 2024-02-13
- Target Recruit Count
- 16
- Registration Number
- NCT06007235
- Locations
- 🇫🇷
Hopital Necker - enfants malades, Paris, France
Post-surgical Scars After the Use of CACIPLIQ20
Phase 3
Recruiting
- Conditions
- Scars
- Interventions
- Device: CACIPLIQ20®Drug: Placebo (saline solution)
- First Posted Date
- 2022-09-06
- Last Posted Date
- 2024-02-13
- Target Recruit Count
- 50
- Registration Number
- NCT05528328
- Locations
- 🇫🇷
CHU Brest, Brest, Bretagne, France
🇫🇷Clinique Turin, Paris, Ile De France, France
MAtrix Therapy for Hard-to-heal ChrOnic Wounds
Not Applicable
Recruiting
- Conditions
- Arterial UlcerDiabetic Foot UlcerChronic Ulcer of Leg or FootVenous Ulcer of Leg
- First Posted Date
- 2021-12-28
- Last Posted Date
- 2023-11-01
- Target Recruit Count
- 200
- Registration Number
- NCT05170984
- Locations
- 🇫🇷
Réseau Cicat-Occitanie, Montpellier, France
An Open, Study to Assess the Safety of RGTA® (OTR4132) in Patients With Acute Ischemic Stroke (AIS)
Not Applicable
Completed
- Conditions
- Stroke, Acute
- First Posted Date
- 2019-09-10
- Last Posted Date
- 2024-08-02
- Target Recruit Count
- 19
- Registration Number
- NCT04083001
- Locations
- 🇫🇷
CHU Grenoble Alpes, Grenoble, Auvergne Rhône Alpes, France
🇫🇷CHU Nancy, Nancy, Grand Est, France
🇫🇷CHU Bordeaux Pellegrin, Bordeaux, Nouvelle Aquitaine, France
- Prev
- 1
- 2
- Next
News
No news found